The COVID-19 pandemonium continues: (Withdrawal of published clinical studies in Lancet and N Engl J Med, 2020).
作者信息
Woodcock Barry G
出版信息
Int J Clin Pharmacol Ther. 2020 Aug;58(8):415-416. doi: 10.5414/CP203848.
DOI:10.5414/CP203848
PMID:32646541
Abstract
摘要
相似文献
1
The COVID-19 pandemonium continues: (Withdrawal of published clinical studies in Lancet and N Engl J Med, 2020).新冠疫情仍在肆虐：（2020年《柳叶刀》和《新英格兰医学杂志》撤回已发表的临床研究）
Int J Clin Pharmacol Ther. 2020 Aug;58(8):415-416. doi: 10.5414/CP203848.
2
Editorial: Clinical trial design in the era of COVID-19.社论：新冠疫情时代的临床试验设计
Clin Trials. 2020 Oct;17(5):465-466. doi: 10.1177/1740774520940230. Epub 2020 Jul 10.
3
Research in the context of coronavirus disease 2019: Considerations for critical care environments.2019冠状病毒病背景下的研究：重症监护环境的考量
Aust Crit Care. 2020 Jul;33(4):309-310. doi: 10.1016/j.aucc.2020.06.004.
4
Audio Interview: A New Monoclonal Antibody for Covid-19.音频访谈：一种用于治疗新冠病毒病的新型单克隆抗体
N Engl J Med. 2020 Oct 29;383(18):e117. doi: 10.1056/NEJMe2032410.
5
Randomized Clinical Trials and COVID-19: Managing Expectations.随机临床试验与 COVID-19：合理期待管理
JAMA. 2020 Jun 9;323(22):2262-2263. doi: 10.1001/jama.2020.8115.
6
Editorial - COVID-19.社论 - 2019冠状病毒病
Br J Haematol. 2020 Apr;189(2):207. doi: 10.1111/bjh.16678.
7
COVID-19: a catalyst for flexibility and creativity in neurology.新冠疫情：神经学灵活性与创造力的催化剂
Lancet Neurol. 2020 Jul;19(7):557. doi: 10.1016/S1474-4422(20)30176-9.
8
Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists.重症新型冠状病毒2型感染：重症监护医生的实际考量与管理策略
Intensive Care Med. 2020 Apr;46(4):579-582. doi: 10.1007/s00134-020-05967-x. Epub 2020 Feb 26.
9
Include pregnant women in research-particularly covid-19 research.将孕妇纳入研究——尤其是新冠病毒-19研究。
BMJ. 2020 Aug 25;370:m3305. doi: 10.1136/bmj.m3305.
10
COVID-19 Antibody Trials Have Begun.新冠病毒抗体试验已经开始。
JAMA. 2020 Jul 14;324(2):128. doi: 10.1001/jama.2020.11582.
Zotero 插件